Tilray Brands Inc TLRY shares are trading higher Wednesday in anticipation of a Senate marijuana meeting.
The Senate Judiciary Subcommittee on Crime and Terrorism has scheduled a meeting, titled "Decriminalizing Cannabis at the Federal Level: Necessary Steps to Address Past Harms." It's likely that senators on the panel will be debating the potential decriminalization of marijuana at the federal level.
Reports suggest that the long-awaited legislation could be introduced as soon as this week, although the meeting is currently scheduled for July 26.
An outline of the Cannabis Administration & Opportunity Act (CAOA) was released about one year ago. The outline shows plans to remove marijuana from the Controlled Substances Act and expunge prior convictions. It also includes resentencing measures.
Tilray is set to announce its fiscal fourth-quarter financial results before the market opens on July 28.
TLRY Price Action: Tilray has a 52-week high of $16.67 and a 52-week low of $3.
The stock was up 14% at $4.05 at press time, according to data from Benzinga Pro.
Photo: Herbal Hemp from Pixabay.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Meet the biggest cannabis industry players and make deals that will push the industry forward.
Featuring live company presentations, insider panels, and unmatched access to networking, the Benzinga Cannabis Capital Conference is where cannabis executives and entrepreneurs meet.
Join us September 13-14, 2022 at The Palmer House in Chicago, IL.